News & Events
-
April 22, 2020 - April 23, 2020
11th Annual Patient-Reported Outcome Consortium Workshop
The Eleventh Annual Patient-Reported Outcome Consortium Workshop will be on Wednesday, April 22 and Thursday, April 23, 2020 at the Sheraton Silver Spring, in Silver Spring MD. A detailed agenda and logistics are currently being developed and will be shared when available.
This Workshop is open to the public and requires registration. For questions or registration information please contact Janelle Russell.
-
March 30, 2020 - March 31, 2020
2020 DIA Digital Technology in Clinical Trials Conference
The ePRO Consortium is pleased to be a co-sponsor of the upcoming 2020 DIA Digital Technology in Clinical Trials Conference to be held from March 30-31, 2020 in Boston, MA. This multi-track conference will bring together thought-leaders from regulatory agencies, biotech, pharmaceutical, patients, and academia to discuss the latest advances, challenges, and forward-thinking approaches for...... -
December 6, 2019
C-Path Executive Directors to serve as panelists for FDA Public Workshop
C-Path is pleased to announce that Diane Stephenson, PhD, Executive Director Critical Path for Parkinson’s Consortium and Stephen Joel Coons, PhD, Executive Director Patient-Reported Outcome Consortium have been invited to serve as panelists for the U.S. Food and Drug Administration’s Public Workshop on Patient-Focused Drug Development: Guidance 4 – Incorporating Clinical Outcome Assessments into Endpoints...... -
October 29, 2019
2019 Annual Meeting and Regulatory Science Workshop
October 29, 2019 Crystal Gateway Marriott | Arlington, VA The key objectives of the meeting are: To discuss the proposed strategy for CPAD of developing comprehensive solutions for AD drug development, based on a quantitative understanding of disease progression across the entire AD continuum To review and define a path to advance the progress of...... -
September 9, 2019 - September 10, 2019
Solutions to Drug Development Challenges Workshop: Utilizing Quantitative Approaches, Data Sharing, and Novel Biomarkers
Title Presenter Presentation Link Introduction Dr. John-Michael Sauer (C-Path) Keynote Address Dr. Joseph Scheeren (C-Path) Welcoming Remarks Dr. Janet Woodcock (US FDA) Session 2: Benefits of DDT progression to regulatory acceptance Moderators: Dr. Inish O’Doherty (C-Path) and Dr. Ameeta Parekh (US FDA) 2.1 A perspective on the history and evolution of drug development......